Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 81 Warning: fopen(/home/virtual/e-kjs/journal/upload/ip_log/ip_log_2024-05.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 83 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84 The Physiological Occlusion of the Central Canal May Be a Prerequisite for Syringomyelia Formation

The Physiological Occlusion of the Central Canal May Be a Prerequisite for Syringomyelia Formation

Article information

Neurospine. 2023;20(4):1346-1357
Publication date (electronic) : 2023 December 31
doi : https://doi.org/10.14245/ns.2346834.417
1Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China
2Spine Center, China International Neuroscience Institute (CHINA-INI), Beijing, China
3Research Center of Spine and Spinal Cord, Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China
4Lab of Spinal Cord Injury and Functional Reconstruction, China International Neuroscience Institute (CHINA-INI), Xuanwu Hospital, Capital Medical University, Beijing, China
5Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China
6Capital Medical University, Beijing, China
Corresponding Author Fengzeng Jian China International Neuroscience Institute (CHINA-INI), Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing 100053, China Email: jianfengzeng@xwh.ccmu.edu.cn
*Chuan Jiang and Xinyu Wang contributed equally to this study as co-first authors.
Received 2023 August 9; Revised 2023 September 23; Accepted 2023 September 25.

Abstract

Objective

Syringomyelia is a common central nervous system disease characterized by the dilation of the central canal (CC). Regarding the pathogenesis of syringomyelia, cerebrospinal fluid (CSF) circulation obstruction in the subarachnoid space (SAS) of the spinal cord has been widely accepted. However, clinical and animal studies on obstructing the CSF in SAS failed to form syringomyelia, challenging the theory of SAS obstruction. The precise pathogenesis remains unknown.

Methods

We utilized an extradural compression rat model to investigate the pathogenesis underlying syringomyelia. Magnetic resonance imaging enabled detection of syringomyelia formation. To assess CSF flow within the SAS, Evans blue was infused into the cisterna magna. Histological analysis allowed morphological examination of the CC. Furthermore, CSF flow through the CC was traced using Ovalbumin Alexa-Flour 647 conjugate (OAF-647). Scanning electron microscopy (SEM) enabled visualization of ependymal cilia.

Results

The findings showed that the dura mater below the compression segment exhibited lighter coloration relative to the region above the compression, indicative of partial obstruction within the SAS. However, the degree of SAS occlusion did not significantly differ between syringomyelia (SM-Y group) and those without (SM-N group). Intriguingly, hematoxylin and eosin staining and CSF tracing revealed occlusion of the CC accompanied by reduced CSF flow in the SM-Y group compared to SM-N and control groups. SEM images uncovered impairment of ependymal cilia inside the syringomyelia.

Conclusion

CC occlusion may represent a physiological prerequisite for syringomyelia formation, while SAS obstruction serves to initiate disease onset. The impairment of ependymal cilia appears to facilitate progression of syringomyelia.

INTRODUCTION

Characterized by central canal (CC) dilation, syringomyelia forms fluid-filled cavities in the spinal cord, causing dissociative sensory loss, atrophy, and deformities [1-3]. Although the pathogenesis of syringomyelia is still unclear, the restriction of cerebrospinal fluid (CSF) flow in the subarachnoid space (SAS) is hypothesized as a primary factor [4]. However, clinical cases like spinal tumors/stenosis with SAS obstruction often lack syringomyelia [5-7]. Moreover, Berliner et al. [8] failed to induce syringomyelia in rats by suturing the spinal dura to restrict SAS CSF flow. These findings suggest SAS obstruction alone may not underlie syringomyelia pathogenesis.

The CC is a longitudinal tubular structure extending from the fourth ventricle to the conus medullaris, forming the filum terminale [9,10]. Kaolin-induced spinal cord injury elicits syringomyelia accompanied by CC occlusion, suggesting CC patency may contribute to pathogenesis [11,12]. Ependymal cilia lining the CC regulate CSF circulation; their loss causes CSF turbulence and CC expansion [13-15]. Therefore, we investigated the underlying mechanism of syringomyelia by an extradural compression-induced syringomyelia rat model [16]. We found CC occlusion may be a physiological prerequisite for syringomyelia formation in addition to SAS obstruction. Moreover, declining ependymal cilia may promote syringomyelia progression. In summary, our findings indicate CC occlusion, SAS obstruction, and ependymal cilia dysfunction synergistically contribute to a multifactorial pathogenesis of syringomyelia.

MATERIALS AND METHODS

1. Animals and Grouping

Female Sprague-Dawley rats aged 7 weeks and weighing 180–220 g were utilized for this study (Beijing Vital River Laboratory Animal Technology, Beijing, China) with approval from the Animal Ethics Committee of the Animal Experiment Center of Xuanwu Hospital, in accordance with China Animal Management Regulations. A total of 70 rats were utilized in this study, with 54 rats undergoing epidural compression and 16 rats undergoing sham operation. At 28 days postoperation (POD), magnetic resonance imaging (MRI) scans were performed. Of the 16 sham-operated rats and 24 of the 54 epidurally compressed rats, no syringomyelia was exhibited, while syringomyelia was exhibited in 30 of the 54 epidurally compressed rats. Rats were selected based on syringomyelia presence on MRI and divided into 3 groups: (1) control group (n= 16) undergoing sham operation; (2) SM-Y group (n= 21) exhibiting syringomyelia on MRI at 28 POD; and (3) SM-N group (n= 21) with extradural compression but no syringomyelia on MRI at 28 POD. All rats were sacrificed on the day of MRI testing (Fig. 1). Notably, syringomyelia in the SM-Y group (21 of 21) were consistently localized to adjacent segments (T10–12) rostral to the compression (T13). The number of rats per experiment was shown in Table 1.

Fig. 1.

Magnetic resonance imaging of rats in the median sagittal and axial planes at T12, T13, and L1. (A) Control group. (B) Beaded-like syringomyelia (white arrow) at T11–12 defining the SM-Y group. (C) No syringomyelia formation in the SM-N group. Red arrow indicates cotton strip compression site. SM-Y, rats exhibited syringomyelia following extradural compression; SM-N, rats did not develop syringomyelia despite the compression.

The number of rats per experiment

2. Surgical Procedures

The surgical protocol has been described previously [16]. In brief, general anesthesia was induced with 2% enflurane, 70% nitrous oxide, and 30% oxygen. Rats were positioned prone on a thermostatic operating table with limb fixation. Body temperature was maintained at 36°C while monitoring heart and respiratory rates. A 3-cm midline skin incision was made over the T12–13 spinous processes. Using an operating microscope, the paraspinal muscles and T12–13 intervertebral space were carefully dissected to expose the epidural space and ligamentum flavum. The ligamentum flavum was then incised with microscissors. A hand-twisted cotton strip was inserted caudally beneath the T13 lamina into the epidural space. After irrigation with saline, the musculature and skin were sutured closed. For sham operations, the ligamentum flavum was incised without cotton insertion. Topical penicillin was applied post-operatively to prevent infection.

3. In Vivo MRI

Detailed procedures have been described in our previous study [16]. A 7.0 Tesla MRI scanner (PharmaScan 7T, Bruker Corp., Karlsruhe, Germany) equipped with 400 mT/m gradients was utilized at the Animal Imaging Experimental Center, Capital Medical University. Rats were positioned prone on the scanner bed with trunk restraints. Anesthesia was induced with 4% isoflurane in oxygen and maintained with 2% isoflurane via a rat mask during scanning. Following rapid whole-body localization scans in 3 planes, fat-suppressed rapid acquisition with relaxation enhancement sequences acquired T2-weighted sagittal and axial images centered on the surgical site. A 89-mm rat volume coil enabled radiofrequency transmission and signal detection. The imaging parameters for sagittal acquisition were time of repetition/time of echo (TR/TE)= 3,000/33 msec, matrix size = 256 × 256, field of view (FOV) = 60 × 40 mm2, slice thickness= 600 m with no gap, number of slices= 10, number of excitation (NEX)= 8, and resolution= 0.147× 0.147× 1 mm3. The imaging parameters for axial acquisition were TR/TE = 4,500/33 msec, matrix size= 256× 256, FOV= 60× 40 mm2, slice thickness=1 mm with no gap, the number of slices=30, NEX=8, and resolution= 0.147 × 0.147 × 1 mm3. Image data were processed using RadiAnt DICOM Viewer software (ver. 4.6.9, Medixant, Poznan, Poland).

4. CSF Tracer in the SAS

To visualize CSF flow within the SAS, 2.5% Evans blue (EB) was infused into the cisterna magna as a CSF tracer via a cannula. The cannula implantation followed as a published procedure [17]. Briefly, following general anesthesia and prone positioning, a small longitudinal incision was made over the occipital and cervical bones. Tissues and muscles were dissected to expose the atlanto-occipital fascia. A 34G needle punctured the membrane, through which a 4-cm long 0.28-mm internal diameter polyethylene-10 cannula filled with saline was inserted to a depth of 250–300 μm. Laminectomies were then performed at T10 and L2 to expose the transparent dura mater. Using a syringe pump (R462, RWD Life Science Co., Shenzhen, China), 150 μL of 2.5% EB was continuously infused through the cannula over 30 minutes. The puncture site and cannula were sealed with superglue to prevent CSF or EB leakage.

An operating microscope coupled to a real-time camera (Daofeng Corp., Beijing, China) and image processing software (SEYE, ver. 1.6.0.11) recorded the entire experimental procedure. Still images of the T10 and L2 dura mater were captured 30 minutes after initiating EB infusion. Dura mater grayscale values (range: 0= black to 255= white) at T10 and L2 were quantified using ImageJ (ver. 1.8.0.112, National Institute Health, Bethesda, MD, USA). To assess potential SAS obstruction, L2 grayscale values in SM-Y and SM-N groups were compared to control values, under the premise of comparable T10 grayscale across groups. The difference (D-value) between T10 and L2 grayscale values in SM-Y and SM-N groups was calculated to determine the degree of SAS occlusion (D-value = grayscale value of L2 - grascale value of T10).

5. CSF Tracer in the CC

To visualize CSF flow within the CC, ovalbumin conjugated to Alexa Fluor 647 (OAF-647, 45 kDa; Thermo Fisher Scientific Inc., Waltham, MA, USA) was injected into the cisterna magna as a CSF tracer using a micromanipulator-guided microsyringe. Briefly, the atlanto-occipital fascia was exposed as described for cannula implantation. A 10-μL microsyringe with a 30G beveled needle mounted on a stereotactic micromanipulator was inserted through the fascia. Five microliter of 25-μg/μL OAF-647 was gently administered over 1 minute, after which the needle was left in place to prevent leakage. At 10 or 20 minutes postinjection, animals were perfused and fixed in the supine position. Spinal cords were fixed in 4% paraformaldehyde for 24 hours and cryoprotected in 30% sucrose overnight at 4°C before embedding in optimal cutting temperature compound. 20- μm cryosections were collected, washed in phosphate-buffered saline (PBS), and coverslipped with DAPI (4’,6-diamidino-2-phenylindole). Images were acquired on a Zeiss Axio Imager Z2 confocal microscope (Carl Zeiss Microimaging, München, Germany).

6. Hematoxylin and Eosin Staining

For animal perfusion and fixation, 2,000-IU heparin in 500-mL phosphate-buffered saline was administered via intracardiac injection, followed by 500 mL 4% paraformaldehyde in 0.1M PBS at a flow rate of 40 mL/min. Successful perfusion was indicated by liver blanching. Spinal cords were carefully dissected and postfixed in 4% paraformaldehyde in 0.1M PBS overnight at 4°C. Fixed spinal cords were then dehydrated, embedded in paraffin, and sectioned at 4 μm collecting one section per 40-μm interval. Hematoxylin and eosin (HE) staining was performed, and all stained sections were digitally scanned using a high-resolution whole slide scanner (Panoramic MIDI, 3DHISTECH, Budapest, Hungary).

7. Scanning Electron Microscope

Following general intracardiac perfusion, spinal cords were dissected and stored at 4°C in a fixative containing 4% paraformaldehyde and 2.5% glutaraldehyde for 24 hours. Samples were longitudinally sectioned to expose the CC surface, washed in PBS, and postfixed in 1% OsO4 solution for 2 hours. Tissues underwent sequential dehydration in graded ethanol (50%, 70%, 80%, 90%, 100% x3) for 15 minutes per step before critical point drying. Dried samples were examined under an environmental scanning electron microscope Quanta 200 (FEI, Hillsboro, OR, USA) to visualize tissue ultrastructure and acquire images.

8. Statistical Analysis

Quantitative data including EB grayscale values and cilia counts were analyzed using Student t-test, 1-way analysis of variance (ANOVA), and 2-way ANOVA, as appropriate. A p-value ≤ 0.05 was considered statistically significant (ns p > 0.05, *p ≤ 0.05, **p ≤ 0.005, ***p ≤ 0.0005, ****p ≤ 0.00005 in Figs. 24). Results are expressed as mean ± standard deviation. All statistical analyses were performed using GraphPad Prism software (v7.02, GraphPad Software Inc., La Jolla, CA, USA).

Fig. 2.

The epidural infusion of Evans blue (EB) dye and grayscale analysis of the thoracic and lumbar spinal cord. (A, B) Representative images of the dura mater at the T10 and L2 spinal levels prior to EB infusion. (C-H) Representative images at 30 minutes after infusion of 2.5% EB solution at 5 μL/min into the cisterna magna. Control group (C, D), SM-Y group (E, F), and SM-N group (G, H, I). Cannula implantation in the cisterna magna sealed with superglue to prevent cerebrospinal fluid leakage (red rectangle: cisterna magna; yellow line: occipital margin). (J–L) Quantitative analysis of grayscale values (0 = black, 255 = white, lower grayscale values indicate darker coloration) among the 3 groups. (J) No significant differences in grayscale values at the T10 spinal level between groups. (K) Significant differences in grayscale values between T10 and T12 in the SM-Y and SM-N groups but not in controls. (L) No significant differences in the T10 to T12 grayscale value changes (D-values) between the SM-Y and SM-N groups (ns p > 0.05, *p ≤ 0.05, **p ≤ 0.005, yellow dashed line: laminectomy site and dura mater). SM-Y, rats exhibited syringomyelia following extradural compression; SM-N, rats did not develop syringomyelia despite the compression; ns, not significant.

Fig. 3.

Histological analysis of central canal (CC) morphology from T11 to L1 spinal levels (hematoxylin and eosin stain). (A) Normal CC morphology in the control group. (B) Syringomyelia formation rostral to the compression site in the SM-Y group, with CC occlusion at L1. (C) No syringomyelia formation or CC occlusion in the SM-N group. (D) Quantitative comparison of CC cross-sectional area from T11 to L1 among the control, SM-Y, and SM-N groups. Overall views were imaged at 4 × magnification while insets were at 20 × (ns p > 0.05, *p ≤ 0.05, **p ≤ 0.005). SM-Y, rats exhibited syringomyelia following extradural compression; SM-N, rats did not develop syringomyelia despite the compression; ns, not significant.

Fig. 4.

Scanning electron microscopy analysis of ependymal cilia morphology. (A, B) Normal cilia appearance in the central canal of control rats. (C, D) Intact ependymal cilia observed at the T12 region in the SM-N group. (E, F) Reduced cilia density at T13 in the SM-N group. (G, H) Severe cilia loss within syringomyelia at T12 of the SM-Y group. (I, J) Similarly reduced cilia density at T13 in the SM-Y group. (K) Quantitative comparison of cilia number at the compression segment (CS) and rostral adjacent segments (RS) among groups (ns p > 0.05, ****p ≤ 0.0005). SM-Y, rats exhibited syringomyelia following extradural compression; SM-N, rats did not develop syringomyelia despite the compression; ns, not significant.

9. Ethics Approval and Consent to Participate

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. (Experimental Animal Welfare Ethics Committee, Xuanwu Hospital, Capital Medical University, no. XWH2019002).

RESULTS

1. Degree of SAS Obstruction Showed No Difference Between SM-Y and SM-N Groups

We first examined the relationship between syringomyelia occurrence and SAS obstruction. Representative images show exposed dura mater before and after EB injection across groups (Fig. 2AH). Cannula implantation in the cisterna magna is depicted (Fig. 2I). No significant difference in T10 grayscale values (0= black, 255= white, lower grayscale values indicate darker coloration) was found among groups (Fig. 2J). Compared to T10 values and controls, L2 grayscale values were significantly increased in both SM-Y and SM-N groups (Fig. 2K), indicating SAS obstruction due to extradural compression. However, no significant difference in T10–L2 grayscale value differences (D-values) existed between SM-Y and SM-N (Fig. 2L), suggesting the degree of SAS obstruction did not correlate with syringomyelia occurrence. In summary, while extradural compression caused SAS obstruction that may contribute to pathogenesis, the severity alone did not determine syringomyelia development.

2. SM-Y Group Showed an Occlusion of CC and the Slowest CSF Flow

To investigate the role of the CC in syringomyelia, we examined CC morphology and CSF flow. HE staining revealed CC occlusion with ependymal cell adhesion exclusively in the SM-Y group, while the CC remained patent at corresponding spinal levels in controls and the SM-N group. Quantitative evaluation demonstrated dramatically increased CC area at T11 and T12 in the SM-Y versus control and SM-N groups, indicative of syringomyelia formation. However, the CC area sharply decreased at L1 in SM-Y compared to controls and SM-N. Notably, occlusion occurred not centrally at the compression but rather at the caudal CC between T13 and L1. Without occlusion, the SM-N group exhibited a slight but insignificant expansion trend at T11-T13 (Fig. 3).

Furthermore, we examined how extradural compression impacts CSF flow within the CC. The T13 segment, located above the occlusion at the caudal end of the syringomyelia, was selected for analysis to best reflect overall CSF dynamics through the intact CC. Observation of CSF tracer distribution at this site allowed assessment of flow changes affecting the entire CC. At 10 minutes postinjection of the OAF-647 tracer, fluorescence signal was detected only within the CC of controls (Fig. 5A). However, by 20 minutes postinjection, signal was observed in the CC of controls and the SM-N group (Fig. 5D, E) but remained absent in the SM-Y group (Fig. 5F). These findings indicate extradural compression slows CSF velocity within the CC regardless of syringomyelia presence, with greater impedance of flow in the SM-Y versus SM-N groups. CC occlusion may further retard CSF dynamics, representing a key physiological disturbance underlying abnormal CSF flow and syringomyelia pathogenesis.

Fig. 5.

Analysis of cerebrospinal fluid tracer Ovalbumin Alexa-Flour 647 conjugate (OAF-647) distribution in the central canal (CC). (A–C) At 10 minutes postinjection, no OAF-647 fluorescence signal was detected in the CC at T13 in the SM-Y and SM-N groups compared to controls. (D–F) At 20-minute postinjection, a faint OAF-647 signal was observed in the CC of the SM-N group compared to controls, while no signal was still detectable in the SM-Y group CC. Overall views were acquired at 4 × magnification, while insets were at 20 × . OAF-647 fluorescence is shown in green and DAPI (4´,6-diamidino-2-phenylindole) nuclear counterstain in blue. SM-Y, rats exhibited syringomyelia following extradural compression; SM-N, rats did not develop syringomyelia despite the compression.

3. The Decline of Cilia in Syringomyelia

Previous studies have demonstrated declining cilia within the CC in syringomyelia animal models and human autopsies [18,19]. We thus examined CC cilia status via scanning electron microscopy. In controls, abundant cilia lined the CC lumen (Fig. 4A, B). However, at the compression segment, cilia were markedly reduced in both SM-Y and SM-N groups compared to controls, without significant difference between SM-Y and SM-N. Notably, cilia loss extended to the inner wall of syringomyelia, while the intact cilia observed in corresponding regions in controls and SM-N (Fig. 4CK). The extensive cilia decline accompanying CC occlusion in the SM-Y group may contribute to the greater impedance of CSF flow compared to the SM-N group. These results suggest dysfunctional cilia, both at the compression and adjacent rostral segments, may play a role in promoting the progression of syringomyelia.

DISCUSSION

1. The SAS Obstruction Is Not the Only Cause of Syringomyelia

Although the mechanism underlying syringomyelia remains controversial, SAS obstruction has been recognized as a key contributing factor [4,20]. The widely accepted hypothesis posits that SAS obstruction creates a fluid pressure gradient between the SAS and CC, increasing CSF influx into the “SAS-spinal parenchyma-CC” pathway via perivascular spaces, resulting in fluid accumulation and syringomyelia formation. Relevant molecular mechanisms have been discussed for decades [21-27]. Clinically, contrast-enhanced studies reveal increased CC signal in syringomyelia patients versus controls, suggesting excessive SAS CSF influx into the CC [28]. Additionally, surgical SAS decompression for obstruction (e.g., Chiari I malformation, arachnoiditis) often successfully resolves syringomyelia [29,30]. However, transverse SAS ligation failed to induce syringomyelia in rats. Furthermore, clinical SAS obstruction from spinal tumors or stenosis impedes CSF flow but does not always induce syringomyelia [5-8]. In this study, instead of post-mortem fluorescence staining, we continuously pumped EB dye into the cisterna magna of living animals to observe color changes in the dura mater above and below the compression site, determining SAS obstruction. Although the compression did cause SAS obstruction both in SM-Y and SM-N group compared to control, the degree of SAS obstruction did not correlate with syringomyelia formation. Collectively, these findings challenge the notion that SAS obstruction alone underlies syringomyelia pathogenesis.

2. CC Occlusion Is Correlated With Syringomyelia Occurrence

Aside from the SAS, the CC represents another important CSF pathway. In contrast to occlusion in humans, studies demonstrate patency of the CC in rats, which functions as a channel for CSF outflow. In rats, the CC directly receives CSF from the fourth ventricle and excretes it into the blood via the terminal filament and cauda equina [30-32]. The CC’s role in syringomyelia remains hypothetical due to a lack of methods to selectively occlude the CC without spinal cord injury in animals. Here, we examined CC morphology and CSF flow. CC occlusion was observed at the T13–L1 junction exclusively in the SM-Y group, while the CC remained patent in SM-N. Moreover, CSF trace showed that the CSF flow velocity in the CC was significantly reduced in both SM-Y and SM-N compared to controls, with greater impedance and stasis in SM-Y. Notably, we did not use OAF-647 to evaluate CSF flow in the SAS because of the concerns over dural damage from tissue extraction. Compare to EB infusion in living animal, post-mortem staining risked generating ambiguous, misleading data of CSF flow in SAS. These findings suggest CC occlusion, potentially resulting from extradural compression, dramatically slows CSF flow through the CC. Along with SAS obstruction, CC occlusion may represent a necessary condition for syringomyelia formation by disrupting CSF dynamics.

3. The Decline of Ependymal Cilia in Syringomyelia

As mentioned, CSF flow was reduced in SM-N versus controls despite an open CC, suggesting additional factors contribute to flow impedance. Lining the ventricles and CC, multiciliated ependymal cells bear motile cilia that coordinate CSF movement [33]. Ependymal cilia dysfunction can lead to CC flow turbulence [15,34]. In kaolin-induced syringomyelia, cilia shedding and lodging in syringomyelia was observed [18]. Moreover, human autopsies revealed stretched, deciliated ependyma in syringomyelic cords [19]. Clinical and animal studies confirm ependymal cilia loss causes ventricular expansion and fluid accumulation [35,36]. Here, cilia decline was observed within syringomyelia in SM-Y, aligning with literature. However, intact cilia were noted at T10–12 in SM-N despite declines at the T13 compression. This suggests cilia dysfunction at the compression site may slow CSF flow in SM-N. Overall, concurrent with CC occlusion, extensive cilia impairment along the CC critically slowed flow and may promote CC dilation and syringomyelia development.

4. Clinical Relevance

Physiological differences between rats and humans likely underlie the distinct CC functions. In rats, the CC remains patent, comprising an integral pathway for CSF circulation from the ventricles through the cauda equina/conus into the bloodstream [32]. In contrast, little is known regarding normal human CC function. Numerous histological findings and morphometric analysis of human CC have been published in the past few decades. Cornil and Mosinger [37] found 71% CC occlusion from randomly selected sections of human spinal cord and suggested the occlusion was due to ependymal cells proliferation and gliovascular scarring, while Netsky [38] found that nearly 80% CC was occluded. In 1994, Milhorat et al. [39] described the first detailed histological study of human CC in 232 subject ranging in age from 6 weeks to 92 years. The stenosis process was mostly observed at T2–8 segment of spinal cord and involved higher grades of CC occlusion in elder subject. A histological review revealed that the lumen patency above and below syringomyelia may be an important factor in syringomyelia development, which was consistent with the result in present animal study. In 1995, Milhorat et al. [19] analysied the pathological basis of syringomyelia in 105 autospsy cases, which indicating a 70% CC and 30% eccentric syringomyelia. Thus, since most of the CC is occluded in human, alongside SAS obstruction (e.g., Chiari), syringomyelia may occur. In traumatic syringomyelia, external forces could directly damage ependymal cilia, hastening CC expansion. Though SAS decompression sometimes helps, variable outcomes suggest fixing bidirectional CSF flow between the CC and SAS, not just SAS obstruction, is key for resolution. Reconstructing CC patency may be required alongside SAS decompression to a better outcome.

In this study, CSF flow was only assessed at the T13 level to avoid confounds from syringomyelia size variations at more rostral levels. However, this raises questions regarding CSF dynamics within and above the syringomyelia. To address this, future studies could supplement cisterna magna injections with in situ CSF tracer administration directly into the syringomyelia and rostral CC. This combined approach may provide further insight into CSF flow changes underlying syringomyelia formation and enlargement. Due to the substantial biological differences exist between animal models and human patients, rather than fully replicating clinical scenarios, this model primarily provides insight into possible pathogenetic roles of CC patency and cilia integrity that are challenging to explore in humans.

Furthermore, whether ependymal cilia dysfunction actively promotes syringomyelia development or represents a secondary pathological change in syringomyelia remains unclear. Idiopathic syringomyelia cases lacking SAS obstruction [40,41]. may arise from congenital cilia deficits and CC occlusion. Thus, methods to repair damaged cilia may slow progression and facilitate syringomyelia recovery.

5. Limitations

This study has some limitations to address going forward. First, patients typically develop syringomyelia distal to the compression level, unlike the present model. The mechanisms underlying this discrepancy require further investigation. Second, this model focus on CC rather than eccentric syringomyelia, which have certain limitations to mimic all situations in clinical settings. The pathogenetic mechanisms warrant investigation with more accurate methods and larger sample sizes to quantify CSF dynamics within the CC and SAS. Third, direct visualization of ciliary beating was not feasible in the narrow CC, contrasting brain ventricles. Improved techniques to assess CC cilia motility warrant development.

CONCLUSION

By examining CSF dynamics within the CC and SAS alongside ependymal cilia integrity in an extradural compression-induced syringomyelia rat model, we gained novel insight into syringomyelia pathogenesis. Our findings suggest CC occlusion may be a physiological prerequisite for syringomyelia formation that, in conjunction with SAS obstruction, leads to CSF flow disturbances underlying syringomyelia development. Moreover, declining ependymal cilia appear to facilitate syringomyelia progression. This work highlights the need to look beyond SAS CSF flow and consider the multifaceted roles of CC morphology and ciliary function. Future studies should focus not only on SAS dynamics but also CC patency and ependymal integrity to better elucidate this complex disorder.

Notes

Conflict of Interest

The authors have nothing to disclose.

Funding/Support

This research was supported by grants from the Beijing Municipal Natural Science Foundation (No. 583003) funded by Beijing Municipal Science & Technology Commission (Grant number: Z191199996619048 and L212007).

Author Contribution

Conceptualization: CJ, XW, FJ, CL, LM; Data curation: CJ, XW, KL, WL, SC, XW; Formal Analysis: CJ, YF; Funding acquisition: FJ; Investigation: KL, WL, SC, XW; Methodology: CJ, FJ, XW, KL, WL, SC; Project Administration: CJ, CL, QI, XW; Visualization: CJ, CL, QI, YF; Writing – Original Draft: CJ; Writing – Review & Editing: CJ, XW.

Acknowledgements

We would like to acknowledge our colleagues Lei Cheng, Chenghua Yuan and Penghao Liu from Xuanwu Hospital for advising the current subject. Thanks to other relevant researchers: Jianfeng Lei, Zhanjing Wang, and Wenqi Wu from Capital Medical University for technical support in MRI test; Zixin Zhu, Yufeng Wang and Wenrong Zheng from Animal research center of Xuanwu Hospital for helping in animal feeding and care; Jingjing Wang, Qian Li, Yan Yang and Chenguang Zhao from Tsinghua University for the technical support and guidance of scanning electron microscope.

References

1. Dworkin GE, Staas WE Jr. Posttraumatic syringomyelia. Arch Phys Med Rehabil 1985;66:329–31.
2. Shannon N, Symon L, Logue V, et al. Clinical features, investigation and treatment of post-traumatic syringomyelia. J Neurol Neurosurg Psychiatry 1981;44:35–42.
3. Milhorat TH. Classification of syringomyelia. Neurosurg Focus 2000;8:E1.
4. Stoodley MA, Jones NR, Brown CJ. Evidence for rapid fluid flow from the subarachnoid space into the spinal cord central canal in the rat. Brain Res 1996;707:155–64.
5. Lee TT, Alameda GJ, Gromelski EB, et al. Outcome after surgical treatment of progressive posttraumatic cystic myelopathy. J Neurosurg 2000;92(2 Suppl):149–54.
6. Bonfield CM, Levi AD, Arnold PM, et al. Surgical management of post-traumatic syringomyelia. Spine (Phila Pa 1976) 2010;35(21 Suppl):S245–58.
7. Cacciola F, Capozza M, Perrini P, et al. Syringopleural shunt as a rescue procedure in patients with syringomyelia refractory to restoration of cerebrospinal fluid flow. Neurosurgery 2009;65:471–6. discussion 476.
8. Berliner JA, Woodcock T, Najafi E, et al. Effect of extradural constriction on CSF flow in rat spinal cord. Fluids Barriers CNS 2019;16:7.
9. Yasui K, Hashizume Y, Yoshida M, et al. Age-related morphologic changes of the central canal of the human spinal cord. Acta Neuropathol 1999;97:253–9.
10. Liccardo G, Ruggeri F, De Cerchio L, et al. Fifth ventricle: an unusual cystic lesion of the conus medullaris. Spinal Cord 2005;43:381–4.
11. Cosan TE, Tel E, Durmaz R, et al. Non-hindbrain-related syringomyelia. Obstruction of the subarachnoid space and the central canal in rats. An experimental study. J Neurosurg Sci 2000;44:123–7.
12. Milhorat TH, Nobandegani F, Miller JI, et al. Noncommunicating syringomyelia following occlusion of central canal in rats. Experimental model and histological findings. J Neurosurg 1993;78:274–9.
13. Cantaut-Belarif Y, Sternberg JR, Thouvenin O, et al. The reissner fiber in the cerebrospinal fluid controls morphogenesis of the body axis. Curr Biol 2018;28:2479–86.e4.
14. Grimes DT, Boswell CW, Morante NF, et al. Zebrafish models of idiopathic scoliosis link cerebrospinal fluid flow defects to spine curvature. Science 2016;352:1341–4.
15. Zhang J, Chandrasekaran G, Li W, et al. Wnt-PLC-IP3-Connexin-Ca2+ axis maintains ependymal motile cilia in zebrafish spinal cord. Nat Commun 2020;11:1860.
16. Ma L, Yao Q, Zhang C, et al. Chronic extradural compression of spinal cord leads to syringomyelia in rat model. Fluids Barriers CNS 2020;17:50.
17. Xavier ALR, Hauglund NL, von Holstein-Rathlou S, et al. Cannula implantation into the cisterna magna of rodents. J Vis Exp 2018;(135):57378.
18. Hall P, Godersky J, Muller J, et al. A study of experimental syringomyelia by scanning electron microscopy. Neurosurgery 1977;1:41–7.
19. Milhorat TH, Capocelli AL Jr, Anzil AP, et al. Pathological basis of spinal cord cavitation in syringomyelia: analysis of 105 autopsy cases. J Neurosurg 1995;82:802–12.
20. Ball MJ, Dayan AD. Pathogenesis of syringomyelia. Lancet 1972;2:799–801.
21. Najafi E, Stoodley MA, Bilston LE, et al. Inwardly rectifying potassium channel 4.1 expression in post-traumatic syringomyelia. Neuroscience 2016;317:23–35.
22. Liu S, Lam MA, Sial A, et al. Fluid outflow in the rat spinal cord: the role of perivascular and paravascular pathways. Fluids Barriers CNS 2018;15:13.
23. Zhang Y, Zhang YP, Shields LB, et al. Cervical central canal occlusion induces noncommunicating syringomyelia. Neurosurgery 2012;71:126–37.
24. Brodbelt AR, Stoodley MA, Watling AM, et al. Fluid flow in an animal model of post-traumatic syringomyelia. Eur Spine J 2003;12:300–6.
25. Nesic O, Lee J, Ye Z, et al. Acute and chronic changes in aquaporin 4 expression after spinal cord injury. Neuroscience 2006;143:779–92.
26. Hemley SJ, Bilston LE, Cheng S, et al. Aquaporin-4 expression in post-traumatic syringomyelia. J Neurotrauma 2013;30:1457–67.
27. Berliner J, Hemley S, Najafi E, et al. Abnormalities in spinal cord ultrastructure in a rat model of post-traumatic syringomyelia. Fluids Barriers CNS 2020;17:11.
28. Heiss JD, Jarvis K, Smith RK, et al. Origin of syrinx fluid in syringomyelia: a physiological study. Neurosurgery 2019;84:457–68.
29. Guan J, Yuan C, Zhang C, et al. Intradural pathology causing cerebrospinal fluid obstruction in syringomyelia and effectiveness of foramen magnum and foramen of magendie dredging treatment. World Neurosurg 2020;144:e178–88.
30. Lu C, Ma L, Yuan C, et al. Phenotypes and prognostic factors of syringomyelia in single-center patients with Chiari I malformation: moniliform type as a special configuration. Neurospine 2022;19:816–27.
31. Pérez-Fígares JM, Jimenez AJ, Rodríguez EM. Subcommissural organ, cerebrospinal fluid circulation, and hydrocephalus. Microsc Res Tech 2001;52:591–607.
32. Nakano N, Kanekiyo K, Yamada Y, et al. Structures of filum terminale and characteristics of ependymal cells of its central canal in rats. Brain Res 2019;1707:208–15.
33. Louvi A, Grove EA. Cilia in the CNS: the quiet organelle claims center stage. Neuron 2011;69:1046–60.
34. Thouvenin O, Keiser L, Cantaut-Belarif Y, et al. Origin and role of the cerebrospinal fluid bidirectional flow in the central canal. Elife 2020;9e47699.
35. Davson H, Segal MB. Physiology of the CSF and blood-brain barriers Boca Raton (FL): CRC Press; 1996.
36. Oppelt WW, Adamson RH, Zubrod CG, et al. Further observations on the physiology and pharmacology of elasmobranch ventricular fluid. Comp Biochem Physiol 1966;17:857–66.
37. Cornil L, Mosinger M. Sur les processus prolifératifs de l'épendyme médullaire (rapports avec les tumeurs intra-médullaires et la syringomyélie). Rev Neurol 1933;1:749–54.
38. Netsky MG. Syringomyelia; a clinicopathologic study. AMA Arch Neurol Psychiatry 1953;70:741–77.
39. Milhorat TH, Kotzen RM, Anzil AP. Stenosis of central canal of spinal cord in man: incidence and pathological findings in 232 autopsy cases. J Neurosurg 1994;80:716–22.
40. Roy AK, Slimack NP, Ganju A. Idiopathic syringomyelia: retrospective case series, comprehensive review, and update on management. Neurosurg Focus 2011;31:E15.
41. Struck AF, Carr CM, Shah V, et al. Cervical spinal canal narrowing in idiopathic syringomyelia. Neuroradiology 2016;58:771–5.

Article information Continued

Fig. 1.

Magnetic resonance imaging of rats in the median sagittal and axial planes at T12, T13, and L1. (A) Control group. (B) Beaded-like syringomyelia (white arrow) at T11–12 defining the SM-Y group. (C) No syringomyelia formation in the SM-N group. Red arrow indicates cotton strip compression site. SM-Y, rats exhibited syringomyelia following extradural compression; SM-N, rats did not develop syringomyelia despite the compression.

Fig. 2.

The epidural infusion of Evans blue (EB) dye and grayscale analysis of the thoracic and lumbar spinal cord. (A, B) Representative images of the dura mater at the T10 and L2 spinal levels prior to EB infusion. (C-H) Representative images at 30 minutes after infusion of 2.5% EB solution at 5 μL/min into the cisterna magna. Control group (C, D), SM-Y group (E, F), and SM-N group (G, H, I). Cannula implantation in the cisterna magna sealed with superglue to prevent cerebrospinal fluid leakage (red rectangle: cisterna magna; yellow line: occipital margin). (J–L) Quantitative analysis of grayscale values (0 = black, 255 = white, lower grayscale values indicate darker coloration) among the 3 groups. (J) No significant differences in grayscale values at the T10 spinal level between groups. (K) Significant differences in grayscale values between T10 and T12 in the SM-Y and SM-N groups but not in controls. (L) No significant differences in the T10 to T12 grayscale value changes (D-values) between the SM-Y and SM-N groups (ns p > 0.05, *p ≤ 0.05, **p ≤ 0.005, yellow dashed line: laminectomy site and dura mater). SM-Y, rats exhibited syringomyelia following extradural compression; SM-N, rats did not develop syringomyelia despite the compression; ns, not significant.

Fig. 3.

Histological analysis of central canal (CC) morphology from T11 to L1 spinal levels (hematoxylin and eosin stain). (A) Normal CC morphology in the control group. (B) Syringomyelia formation rostral to the compression site in the SM-Y group, with CC occlusion at L1. (C) No syringomyelia formation or CC occlusion in the SM-N group. (D) Quantitative comparison of CC cross-sectional area from T11 to L1 among the control, SM-Y, and SM-N groups. Overall views were imaged at 4 × magnification while insets were at 20 × (ns p > 0.05, *p ≤ 0.05, **p ≤ 0.005). SM-Y, rats exhibited syringomyelia following extradural compression; SM-N, rats did not develop syringomyelia despite the compression; ns, not significant.

Fig. 4.

Scanning electron microscopy analysis of ependymal cilia morphology. (A, B) Normal cilia appearance in the central canal of control rats. (C, D) Intact ependymal cilia observed at the T12 region in the SM-N group. (E, F) Reduced cilia density at T13 in the SM-N group. (G, H) Severe cilia loss within syringomyelia at T12 of the SM-Y group. (I, J) Similarly reduced cilia density at T13 in the SM-Y group. (K) Quantitative comparison of cilia number at the compression segment (CS) and rostral adjacent segments (RS) among groups (ns p > 0.05, ****p ≤ 0.0005). SM-Y, rats exhibited syringomyelia following extradural compression; SM-N, rats did not develop syringomyelia despite the compression; ns, not significant.

Fig. 5.

Analysis of cerebrospinal fluid tracer Ovalbumin Alexa-Flour 647 conjugate (OAF-647) distribution in the central canal (CC). (A–C) At 10 minutes postinjection, no OAF-647 fluorescence signal was detected in the CC at T13 in the SM-Y and SM-N groups compared to controls. (D–F) At 20-minute postinjection, a faint OAF-647 signal was observed in the CC of the SM-N group compared to controls, while no signal was still detectable in the SM-Y group CC. Overall views were acquired at 4 × magnification, while insets were at 20 × . OAF-647 fluorescence is shown in green and DAPI (4´,6-diamidino-2-phenylindole) nuclear counterstain in blue. SM-Y, rats exhibited syringomyelia following extradural compression; SM-N, rats did not develop syringomyelia despite the compression.

Table 1.

The number of rats per experiment

Variable Control SM-Y group SM-N group
SAS CSF tracing 3 6 6
HE staining 4 6 6
CC CSF tracing (10 min) 3 3 3
CC CSF tracing (20 min) 3 3 3
SEM 3 3 3
Total 16 21 21

SM-Y, rats exhibited syringomyelia following extradural compression; SM-N, rats did not develop syringomyelia despite the compression; SAS, subarachnoid space; CSF, cerebrospinal fluid; HE, hematoxylin and eosin; CC, central canal; SEM, scanning electron microscope.